Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Renalytix Ai Plc ADR (NQ: RNLX )

0.2071 UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.2071
Bid (Size) 0.1400 (1)
Ask (Size) 0.1499 (12)
Prev. Close 0.2071
Today's Range 0.2071 - 0.2071
52wk Range 0.1760 - 2.400
Shares Outstanding 93,781,478
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Commencement of trading on OTCQB in the United States
Renalytix plc American Depository Shares (ADSs) begin trading on OTCQB Venture Market under symbol “RNLXY” effective from Market Open on October 8, 2024 
From Renalytix plc
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga

Performance

YTD
-51.27%
-51.27%
1 Month
N/A
N/A
3 Month
-44.03%
-44.03%
6 Month
-70.03%
-70.03%
1 Year
-80.09%
-80.09%

More News

Read More
Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why ASP Isotopes Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Nasdaq Dips Over 300 Points; PepsiCo Reports Weak Sales
Via Benzinga
Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansion for KidneyIntelX Platform Beyond US
From Renalytix plc
Via GlobeNewswire
Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determination
From Renalytix plc
Via GlobeNewswire
Medicare Issues Final Coverage Determination for kidneyintelX.dkd
From Renalytix plc
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
RNLX Stock Earnings: Renalytix Misses EPS, Misses Revenue for Q3 2024
Via InvestorPlace
Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024
From Renalytix plc
Via GlobeNewswire
Renalytix to Report Financial Results for Third Quarter Fiscal Year 2024 on May 15
From Renalytix plc
Via GlobeNewswire
Renalytix Announces Financing with Expected Size of up to $4 Million
From Renalytix plc
Via GlobeNewswire
3 Ridiculously Enticing Stocks to Buy for Under a Buck
Via InvestorPlace
KidneyIntelX™ included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease (CKD)
From Renalytix plc
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Oracle Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback